Macrophage dysregulation in inflammatory bowel disease: cellular heterogeneity, pathogenic mechanism, and treatment - Summary - MDSpire

Macrophage dysregulation in inflammatory bowel disease: cellular heterogeneity, pathogenic mechanism, and treatment

  • By

  • Yuanyuan Yang

  • Haiying Zhu

  • May 21, 2026

  • 0 min

Share

Objective:

Emphasize the significance of macrophage dysregulation in IBD.

Key Findings:
  • Include context on how findings relate to disease mechanisms.
Interpretation:

Elaborate on 'mechanism-based therapies'.

Limitations:
  • Expand to include future research directions.
Conclusion:

Reiterate the importance of macrophage states in therapy development.

Original Source(s)

Macrophage dysregulation in inflammatory bowel disease: cellular heterogeneity, pathogenic mechanism, and treatment

  • by Yuanyuan Yang, Haiying Zhu

  • May 21, 2026

Related Content

Editorial: Volume II of the Community Series on Gut Microbiota and Immune Interactions in Intestinal Disorders

Link Between Blastocystis Subtypes 3 and 4 and Intestinal Inflammation as Well as Metronidazole Efficacy in Symptomatic Individuals

Evaluation of Tacrolimus in Ulcerative Colitis: A Retrospective Analysis of Factors Influencing Remission Induction and Maintenance